Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$701K Buy
5,458
+409
+8% +$47.9K 0.02% 154
2026
Q1
$607K Buy
5,049
+113
+2% +$13K 0.02% 150
2025
Q4
$520K Buy
4,936
+598
+14% +$56.1K 0.02% 158
2025
Q3
$364K Buy
4,338
+1,074
+33% +$88.5K 0.01% 175
2025
Q2
$258K Buy
3,264
+19
+0.6% +$1.51K 0.01% 214
2025
Q1
$291K Buy
3,245
+647
+25% +$60.4K 0.01% 162
2024
Q4
$258K Sell
2,598
-689
-21% -$71K 0.01% 163
2024
Q3
$373K Sell
3,287
-272
-8% -$32.3K 0.01% 144
2024
Q2
$441K Buy
3,559
+363
+11% +$46.8K 0.02% 136
2024
Q1
$422K Sell
3,196
-172
-5% -$21.2K 0.02% 131
2023
Q4
$347K Hold
3,368
0.02% 128
2023
Q3
$347K Buy
3,368
+94
+3% +$10.1K 0.02% 128
2023
Q2
$378K Buy
3,274
+416
+15% +$47.2K 0.02% 126
2023
Q1
$304K Buy
2,858
+381
+15% +$41.1K 0.02% 132
2022
Q4
$275K Buy
+2,477
New +$253K 0.02% 127

Other funds holding MRK

Foster Group's MRK Position: Q2 2026 in Review

Foster Group increased its Merck (MRK) stake by 8.1% in Q2 2026, buying an estimated $47.9K and bringing the position to 5,458 shares worth $701K. The position accounts for 0.02% of the portfolio, ranked #154.

Foster Group first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Foster Group held 5,458 shares of Merck worth $701K as of Q2 2026.
  • Foster Group bought 409 Merck shares in Q2 2026, an estimated $47.9K.
  • Merck made up 0.02% of Foster Group's portfolio in Q2 2026, its #154 holding.
  • Foster Group first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.